ChiCTR2500097148 版本V1.0 版本创建时间2025/02/13 10:24:11 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500097148 

最近更新日期:

Date of Last Refreshed on:

2025-02-13 10:23:52 

注册时间:

Date of Registration:

2025-02-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

慢性踝关节不稳定的量化评估及优化治疗的临床研究:子课题3 -手术治疗慢性踝关节不稳定的前瞻性研究

Public title:

Clinical study on quantitative evaluation and optimized treatment of chronic ankle instability: Subtopic 3 -Prospective study on surgical treatment of chronic ankle instability

注册题目简写:

English Acronym:

研究课题的正式科学名称:

慢性踝关节不稳定的量化评估及优化治疗的临床研究:子课题3 -手术治疗慢性踝关节不稳定的前瞻性研究

Scientific title:

Clinical study on quantitative evaluation and optimized treatment of chronic ankle instability: Subtopic 3 -Prospective study on surgical treatment of chronic ankle instability

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

白露 

研究负责人:

白露 

Applicant:

Bai Lu  

Study leader:

Bai Lu  

申请注册联系人电话:

Applicant telephone:

+86 13823153064

研究负责人电话:

Study leader's
telephone:

+86 755 83923333

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

boowboow@163.com

研究负责人电子邮件:

Study leader's E-mail:

boowboow@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

深圳市福田区莲花路1120号

研究负责人通讯地址:

深圳市福田区莲花路1120号

Applicant address:

No.1120, Lianhua Road, Futian District, Shenzhen

Study leader's address:

1120 Lian Hua Road, Shenzhen 518036, People's Repubilc of China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学深圳医院运动医学科

Applicant's institution:

Department of Sports Medicine, Peking University Shenzhen Hospital

研究负责人所在单位:

北京大学深圳医院

Affiliation of the Leader:

Peking University Shenzhen Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

北大深医伦审(研)[2024]第(182)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学深圳医院科研伦理委员会

Name of the ethic committee:

Ethics Committee of Peking University Shenzhen Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-12-31 00:00:00

伦理委员会联系人:

陈嘉怡

Contact Name of the ethic committee:

Chen Jiayi

伦理委员会联系地址:

深圳市福田区莲花路1120号

Contact Address of the ethic committee:

1120 Lian Hua Road, Shenzhen 518036, People's Repubilc of China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 755 83923333

伦理委员会联系人邮箱:

Contact email of the ethic committee:

jiayichen25@163.com

研究实施负责(组长)单位:

北京大学深圳医院

Primary sponsor:

Peking University Shenzhen Hospital

研究实施负责(组长)单位地址:

深圳市福田区莲花路1120号

Primary sponsor's address:

1120 Lian Hua Road, Shenzhen 518036, People's Repubilc of China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

北京大学深圳医院

具体地址:

深圳市福田区莲花路1120号

Institution
hospital:

Peking University Shenzhen Hospital

Address:

1120 Lian Hua Road, Shenzhen 518036, People's Repubilc of China

经费或物资来源:

深圳市医学研究专项资金项目

Source(s) of funding:

Shenzhen Medical Research Special Fund Project

研究疾病:

慢性踝关节不稳定,踝关节痛  

Target disease:

Chronic ankle instability, ankle pain

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

探究诊断为慢性踝关节不稳定的患者手术治疗的效果。并对经完成临床评估的量化指标,结合前期对应患者的随访资料,通过临床回顾性研究的方法,探究影响慢性踝关节不稳定及合并症疗效的临床危险因素。  

Objectives of Study:

Explore the effectiveness of surgical treatment for patients diagnosed with chronic ankle instability. And based on the quantitative indicators that have been clinically evaluated and combined with the follow-up data of corresponding patients in the previous stage, a retrospective clinical study was conducted to explore the clinical risk factors that affect the efficacy of chronic ankle instability and comorbidities.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.根据症状、体征、体格检查及影像学检查明确诊断为慢性踝关节不稳定的患者;
2.患者需要 手术治疗;
3.年龄:年满18至50周岁;
4.在慢性踝关节不稳定治疗后有重返运动意愿;
5.双下 肢既往无骨折,韧带损伤,关节病损等未治疗伤情;
6.无下肢骨关节畸形及肌力/肌张力异常疾病;
7.能够获取知情同意并配合测试;

Inclusion criteria

1. Patients diagnosed with chronic ankle instability based on symptoms, signs, physical examination, and imaging examinations; 2. Ability to obtain informed consent and cooperate with testing; 3. Age: Over 18 to 50 years old; 4. Willingness to return to exercise after treatment for chronic ankle instability; 5. Both lower limbs have no previous untreated injuries such as fractures, ligament injuries, joint lesions, etc; 6. No lower limb bone and joint deformities or muscle strength/tension disorders; 7. Ability to obtain informed consent and cooperate with testing;

排除标准:

1. 年龄<18周岁或年龄>50周岁; 2. 患有肌张力异常,神经肌肉疾病等; 3. 合并双下肢既往未治疗的骨折,韧带损伤,关节病损等; 4. 精神疾病或认知障碍者; 5. 踝关节不稳定治疗后无重返运动意愿; 6. 目前正在参加其他临床试验;

Exclusion criteria:

1. Age<18 years old or age>50 years old; 2. Suffering from abnormal muscle tone, neuromuscular disorders, etc; 3. Merge previously untreated fractures, ligament injuries, joint lesions, etc. in both lower limbs; 4. Individuals with mental illness or cognitive impairment; 5. Lack of willingness to return to exercise after ankle instability treatment; 6. Currently participating in other clinical trials;

研究实施时间:

Study execute time:

From 2025-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-03-01 00:00:00 To 2028-12-01 00:00:00

干预措施:

Interventions:

组别:

慢性踝关节不稳定患者

样本量:

100

Group:

Patients diagnosed with chronic ankle instability

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

北京大学深圳医院 

单位级别:

三级甲等 

Institution
hospital:

Peking University Shenzhen Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

AOFAS评分

指标类型:

主要指标

Outcome:

AOFAS score

Type:

Primary indicator

测量时间点:

随访期间

测量方法:

主观评分

Measure time point of outcome:

During the follow-up period

Measure method:

Subjective rating

指标中文名:

Karlsson评分

指标类型:

次要指标

Outcome:

Karlsson score

Type:

Secondary indicator

测量时间点:

随访期间

测量方法:

主观评分

Measure time point of outcome:

During the follow-up period

Measure method:

Subjective rating

指标中文名:

VAS评分

指标类型:

次要指标

Outcome:

VAS score

Type:

Secondary indicator

测量时间点:

随访期间

测量方法:

主观评分

Measure time point of outcome:

During the follow-up period

Measure method:

Subjective rating

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

not shared

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-02-13 10:23:52